Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Truvada for HIV prevention in Botswana (TDF2-OLE)
NCT04318210Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Oct 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
01
Overview
Open-label trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Centers for Disease Control and Prevention. Primary endpoints: Self-reported Drug Adherence Over the Past 3 Days at 12 months and Number of Sex Partners at 12 months. Started Oct 2012; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04318210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04318210.